Determination of stanozolol and 3'-hydroxystanozolol in rat hair, urine and serum using liquid chromatography tandem mass spectrometry

Chemistry Central Journal

Volumn 6, Issue 1, 2012, Pages

  Deshmukh, Nawed I K ^a   Zachar, Gergely ^b   Petróczi, Andrea ^a   Székely, Andrea D ^b   Barker, James ^a   Naughton, Declan P ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Anabolic androgenic steroid; Doping; Hair analysis; LC MS MS; Serum analysis; Urinalysis

Indexed keywords

EID: 84871393395     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-6-162     Document Type: Article

References (47)

1. The World Anti-Doping Agency Laboratory statistics 2005, http://www.wada-ama.org/Documents/Science_Medicine/Anti-Doping_Laboratories/WADA_LaboStatistics_2005.pdf, [accessed on 20.09.2012], The World Anti-Doping Agency.
2. The World Anti-Doping Agency Laboratory statistics 2006, http://www.wada-ama.org/Documents/Science_Medicine/Anti-Doping_Laboratories/WADA_LaboStatistics_2006.pdf, [accessed on 20.09.2012], The World Anti-Doping Agency.
3. The World Anti-Doping Agency Laboratory statistics 2007, http://www.wada-ama.org/Documents/Science_Medicine/Anti-Doping_Laboratories/WADA_LaboStatistics_2007.pdf, [accessed on 20.09.2012], The World Anti-Doping Agency.
4. The World Anti-Doping Agency Laboratory statistics 2008, http://www.wada-ama.org/Documents/Science_Medicine/Anti-Doping_Laboratories/WADA_LaboStatistics_2008.pdf, [accessed on 20.09.2012], The World Anti-Doping Agency.
5. The World Anti-Doping Agency Laboratory statistics 2009, http://www.wada-ama.org/Documents/Science_Medicine/Anti-Doping_Laboratories/Lab_Statistics/WADA_2009_LaboratoryStatisticsReport_Final.pdf, [accessed on 20.09.2012], The World Anti-Doping Agency.
6. The World Anti-Doping Agency Laboratory statistics 2010, http://www.wada-ama.org/Documents/Resources/Statistics/Laboratory_Statistics/WADA_2010_Laboratory_Statistics_Report.pdf, [accessed on 20.09.2012], The World Anti-Doping Agency.
7. The World Anti-Doping Agency The prohibition list 2013, http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pdf, [accessed on 08.10.2012], The World Anti-Doping Agency.
8. The World Anti-Doping Agency WADA technical document-TD2013MRPL http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/Technical_Documents/WADA-TD2013MRPL-Minimum-Required-Performance-Levels-v1-2012-EN.pdf, [accessed on 20.09.2012], The World Anti-Doping Agency.
9. Pozo OJ, Eenoo PV, Deventer K, Lootens L, Grimalt S, Sancho JV, Hernández F, Meuleman P, Leroux-Roels G, Delbeke FT. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry. Steroids 2008, 74(10-11):837-852.
10. World Anti-Doping Agency WADA technical document-TD2010MRPL http://www.wada-ama.org/documents/world_anti-doping_program/wadp-is-laboratories/wada_td2010mrplv1.0_minimum%20required%20performance%20levels_sept%2001%202010_en.pdf, [accessed on 20.09.2012], World Anti-Doping Agency.
11. Mateus-Avois L, Mangin P, Saugy M. Use of ion trap gas chromatography-multiple mass spectrometry for the detection and confirmation of 3'-hydroxystanozolol at trace levels in urine for doping control. J Chromatogr B 2005, 816(1-2):193-201.
12. Kintz P, Cirimele V, Sachs H, Jeanneau T, Ludes B. Testing for anabolic steroids in hair from two bodybuilders. Forensic Sci Int 1999, 101:209-216. 10.1016/S0379-0738(99)00024-9, 10404632.
13. Graham MR, Davies B, Grace FM, Kicman A, Baker JS. Anabolic steroid use patterns of use and detection of doping. Sports Med 2008, 38:505-525. 10.2165/00007256-200838060-00005, 18489196.
14. Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008, 371:1872-1882. 10.1016/S0140-6736(08)60801-6, 18514731.
15. De Cock KJS, Delbeke FT, Van Eenoo P, Desmet N, Roels K. Detection and determination of anabolic steroids in nutritional supplements. J Pharm Biomed Anal 2001, 25:843-852. 10.1016/S0731-7085(01)00396-X, 11377067.
16. Turgeon D, Carrier JB, Chouinard S, Belanger A. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metab Dispos 2003, 31:670-676. 10.1124/dmd.31.5.670, 12695357.
17. Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 2003, 14(10):473-479. 10.1016/j.tem.2003.10.005, 14643063.
18. Hum DW, Belanger A, Levesque E, Barbier O, Beaulieu M, Albert C, Vallee M, Guillemette C, Tchernof A, Turgeon D, Dubois S. Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Ster Biochem Mol Biol 1999, 69:413-423.
19. You L. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. Chem Biol Interact 2004, 147:233-246. 10.1016/j.cbi.2004.01.006, 15135080.
20. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekström L, Rane A. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 2008, 93(7):2500-2506. 10.1210/jc.2008-0218, 18334593.
21. Deshmukh N, Petróczi A, Barker J, Székely AD, Hussain I, Naughton DP. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids. Subst Abuse Treat Prev Policy 2010, 5(7). http://dx.doi.org/10.1186/1747-597X-5-7.
22. Sten T, Finel M, Ask B, Rane A, Ekström L. Non-steroidal antiinflammatory drugs interact with testosterone glucuronidation. Steroids 2009, 74:971-977. 10.1016/j.steroids.2009.07.004, 19643121.
23. Thuyne WV, Delbeke FT. Declared use of medication in sports. Clin J Sport Med 2008, 18:143-147. 10.1097/JSM.0b013e318163f220, 18332689.
24. Tsitsimpikou C, Tsiokanos A, Tsarouhas K, Schamasch P, Fitch K, Valasiadis D, Jamurtas A. Medication use by athletes at the Athens 2004 summer Olympic games. Clin J Sport Med 2009, 19(1):33-38. 10.1097/JSM.0b013e31818f169e, 19124981.
25. Warden SJ. Prophylactic misuse and recommended use of non-steroidal anti-inflammatory drugs by athletes. Br J Sport Med 2009, 43:548-549.
26. Skarberg K, Nyberg F, Engstrom I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res 2009, 15(2):99-106. 10.1159/000199045, 19182484.
27. Jenkinson C, Petroczi A, Naughton DP. Red wine and components flavonoids inhibit UGT2B17 in vitro. Nutrition 2012, 11. http://dx.doi.org/10.1186/1475-2891-11-67.
28. Jenkinson C, Petroczi A, Barker J, Naughton DP. Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation. Steroids 2012, 77(6):691-695. 10.1016/j.steroids.2012.02.023, 22429924.
29. Deshmukh N, Barker J, Petroczi A, Naughton DP. Detection of testosterone and epitestosterone in human hair using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2012, 67-68:154-158.
30. Deshmukh N, Hussain I, Barker J, Petroczi A, Naughton DP. Analysis of anabolic steroids in human hair using LC-MS/MS. Steroids 2010, 75(10):710-714. 10.1016/j.steroids.2010.04.007, 20435054.
31. Kintz P, Cirimele V, Dumestre-Toulet V, Ludes B. Doping control for nandrolone using hair analysis. J Pharm Biomed Anal 2001, 24:1125-1130. 10.1016/S0731-7085(00)00570-7, 11248508.
32. Poelmans S, De Wasch K, De Brabander HF, Van De Wiele M, Courtheyn D, van Ginkel LA, Sterk SS, Delahaut P, Dubois M, Schilt R, Nielen M, Vercammen J, Impens S, Stephany R, Hamoir T, Pottie G, Van Poucke C, Van Peteghem C. Analytical possibilities for the detection of stanozolol and its metabolites. Anal Chim Acta 2002, 473:39-47.
33. Pablo JS, Sánchez-Baeza F, Marco MP. Simultaneous immunochemical detection of stanozolol and the main human metabolite, 3-hydroxy-stanozolol, in urine and serum samples. Anal Biochem 2008, 376:221-228. 10.1016/j.ab.2008.02.009, 18339300.
34. Shen M, Xiang P, Yan H, Shen B, Wang M. Analysis of anabolic steroids in hair: time courses in guinea pigs. Steroids 2009, 74:773-778. 10.1016/j.steroids.2009.04.008, 19397917.
35. Shen M, Yan H, Xiang P, Shen B. Simultaneous determination of anabolic androgenic steroids and their esters in hair by LC-MS-MS. Chromatographia 2009, 70:1381-1386.
36. de Almeida Chuffa LG, de Souza RB, Frei F, de Fátima Paccola Mesquita S, Camargo IC. Nandrolone decanoate and physical effort: histological and morphometrical assessment in adult rat uterus. Anat Rec 2011, 294:335-341.
37. Pieretti S, Mastriota M, Tucci P, Battaglia G, Trabace L, Nicoletti F, Scaccianoce S. Brain nerve growth factor unbalance induced by anabolic androgenic steroids in rat. Med Sci Sports Exerc 2012, doi:10.1249/MSS.0b013e31826c60ea.
38. Breuer ME, McGinnis MY, Lumia AR, Possidente BP. Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation. Horm Behav 2001, 40(3):409-418. 10.1006/hbeh.2001.1706, 11673914.
39. Matrisciano F, Modafferi AM, Togna GI, Barone Y, Pinna G, Nicoletti F, Scaccianoce S. Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior. Neuropharmacology 2010, 58(7):1078-1084. 10.1016/j.neuropharm.2010.01.015, 20138062.
40. Food and drug act Bioanalytical method validation [http://www.fda.gov/downloads/Drugs/.../Guidances/ucm070107.pdf], [accessed on 20.09.2012], Food and drug act.
41. Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci Int 2007, 165:216-224. 10.1016/j.forsciint.2006.05.021, 16781833.
42. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003, 75:3019-3030. 10.1021/ac020361s, 12964746.
43. Cirimele V, Kintz P, Ludes B. Testing of the anabolic stanozolol in human hair by gas chromatography-negative ion chemical ionization mass spectrometry. J Chromatogr B 2000, 740(2):265-271.
44. Thieme D, Grosse J, Sachs H, Mueller RK. Analytical strategy for detecting doping agents in hair. Forensic Sci Int 2000, 107(1-3):335-345.
45. Höld KM, Wilkins DG, Crouch DJ, Rollins DE, Maes RA. Detection of stanozolol in hair by negative ion chemical ionization mass spectrometry. J Anal Toxicol 1996, 20(6):345-349.
46. Min S, Ping X, Baohua S, Jun B, Mengye W. Physiological concentrations of anabolic steroids in human hair. Forensic Sci Int 2009, 184:32-36. 10.1016/j.forsciint.2008.11.014, 19131197.
47. He C, Li S, Liu H, Li K, Liu F. Extraction of testosterone and epitestosterone in human urine using aqueous two-phase systems of ionic liquid and salt. J Chromatogr A 2005, 1082(2):143-149. 10.1016/j.chroma.2005.05.065, 16035355.